Johnson & Johnson
NewslettersA CEO contender left Johnson & Johnson. Was she penalized for saying she wanted to be a CEO?
By Emma Hinchliffe and Joey AbramsDecember 7, 2023
NewslettersJ.M. Smucker’s CFO explains how sales of Uncrustables grew 22% in the latest quarter—and is on its way to being a $1 billion brand
By Sheryl EstradaDecember 7, 2023
By Sheryl EstradaDecember 6, 2023
HealthFacing 50,000-plus lawsuits linking Baby Powder to cancer, Johnson & Johnson mulls a third bankruptcy filing
By Jef Feeley and BloombergOctober 26, 2023
LeadershipGenerative AI is top of mind for all types of leaders, from Treasury Secretary Janet Yellen to J&J CEO Joaquin Duato
By Fortune EditorsOctober 11, 2023
FinanceJ&J CEO Joaquin Duato discusses how he leads during challenging times and why the next decade will be the golden era for health innovation
By Fortune EditorsOctober 3, 2023
HealthJohnson & Johnson hit by 11,000 more lawsuits linking Baby Powder to cancer after judge throws $9 billion settlement case
By Jef Feeley and BloombergSeptember 28, 2023
HealthMcKinsey agrees to pay $230m to settle suits claiming it fueled the opioid epidemic by advising drugmakers like Purdue how to sell painkillers
By Joel Rosenblatt and BloombergSeptember 27, 2023
By Emma Hinchliffe and Joey AbramsSeptember 15, 2023
By Matthew Perrone and The Associated PressSeptember 12, 2023
HealthTylenol poisoning suspect who tried to extort $1 million from Johnson & Johnson to ‘stop the killing’ dies at 76
By Mark Pratt and The Associated PressJuly 11, 2023
LeadershipFrom free Stanford courses at Northrop Grumman to revamped internships at Salesforce, here’s how 9 companies are competing on A.I. talent
By Paolo ConfinoJune 26, 2023
Most Popular
